{"database": "lobbying", "table": "lobbying_activities", "rows": [[2959707, "1622b3fe-0fac-4cee-9f4b-e0f2ec935cba", "Q1", "TIBER CREEK GROUP", 20744, "BEONE MEDICINES USA, INC. (FKA BEIGENE USA, INC.)", 2023, "first_quarter", "MMM", "Issues related to drug pricing and reimbursement for prescription drugs related to Inflation Reduction Act of 2022 (PL 117-169), Subtitle B (Part B and D drug pricing).", "HOUSE OF REPRESENTATIVES,SENATE", 70000, null, 0, 0, "2023-04-14T16:00:28-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2959707"], "units": {}, "query_ms": 3.500988008454442, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}